Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX

被引:122
作者
Dmitriev, IP
Kashentseva, EA
Curiel, DT
机构
[1] Univ Alabama, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA
[4] Univ Alabama, Gene Therapy Ctr, Birmingham, AL 35294 USA
关键词
D O I
10.1128/JVI.76.14.6893-6899.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The utility of the present generation of adenovirus (Ad) vectors for gene therapy applications could be improved by restricting native viral tropism to selected cell types. In order to achieve modification of Ad tropism, we proposed to exploit a minor component of viral capsid, protein IX (pIX), for genetic incorporation of targeting ligands. Based on the proposed structure of pIX, we hypothesized that its C terminus could be used as a site for incorporation of heterologous peptide sequences. We engineered recombinant Ad vectors containing modified pIX carrying a carboxy-terminal Flag epitope along with a heparan sulfate binding motif consisting of either eight consecutive lysines or a polylysine sequence. Using an anti-Flag antibody, we have shown that modified pIXs are incorporated into virions and display Flag-containing C-terminal sequences on the capsid surface. In addition, both lysine octapeptide and polylysine ligands were accessible for binding to heparin-coated beads. In contrast to virus bearing lysine octapeptide, Ad vector displaying a polylysine was capable of recognizing cellular heparan sulfate receptors. We have demonstrated that incorporation of a polylysine motif into the pIX ectodomain results in a significant augmentation of Ad fiber knob-independent infection of CAR-deficient cell types. Our data suggest that the pIX ectodomain can serve as an alternative to the fiber knob, penton base, and hexon proteins for incorporation of targeting ligands for the purpose of Ad tropism modification.
引用
收藏
页码:6893 / 6899
页数:7
相关论文
共 37 条
  • [1] The subgenus-specific C-terminal region of protein IX is located on the surface of the adenovirus capsid
    Akalu, A
    Liebermann, H
    Bauer, U
    Granzow, H
    Seidel, W
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (07) : 6182 - 6187
  • [2] Adenovirus type 37 uses sialic acid as a cellular receptor
    Arnberg, N
    Edlund, K
    Kidd, AH
    Wadell, G
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (01) : 42 - 48
  • [3] Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
    Bergelson, JM
    Cunningham, JA
    Droguett, G
    KurtJones, EA
    Krithivas, A
    Hong, JS
    Horwitz, MS
    Crowell, RL
    Finberg, RW
    [J]. SCIENCE, 1997, 275 (5304) : 1320 - 1323
  • [4] CHARACTERIZATION OF ADENOVIRUS PROTEIN-IX
    BOULANGER, P
    LEMAY, P
    BLAIR, GE
    RUSSELL, WC
    [J]. JOURNAL OF GENERAL VIROLOGY, 1979, 44 (SEP) : 783 - 800
  • [6] Rational design of viral vectors based on rigorous analysis of capsid structures
    Curiel, DT
    [J]. MOLECULAR THERAPY, 2000, 1 (01) : 3 - 4
  • [7] Strategies to adapt adenoviral vectors for targeted delivery
    Curiel, DT
    [J]. ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN, 1999, 886 : 158 - 171
  • [8] An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
    Dmitriev, I
    Krasnykh, V
    Miller, CR
    Wang, MH
    Kashentseva, E
    Mikheeva, G
    Belousova, N
    Curiel, DT
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (12) : 9706 - 9713
  • [9] Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions
    Einfeld, DA
    Schroeder, R
    Roelvink, PW
    Lizonova, A
    King, CR
    Kovesdi, I
    Wickham, TJ
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (23) : 11284 - 11291
  • [10] Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers
    Fechner, H
    Haack, A
    Wang, H
    Wang, X
    Eizema, K
    Pauschinger, M
    Schoemaker, RG
    van Veghel, R
    Houtsmuller, AB
    Schultheiss, HP
    Lamers, JMJ
    Poller, W
    [J]. GENE THERAPY, 1999, 6 (09) : 1520 - 1535